Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
17.2M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
2.83M
-
Shares change
-
-345K
-
Total reported value, excl. options
-
$2.95M
-
Value change
-
-$356K
-
Put/Call ratio
-
0.57
-
Number of buys
-
16
-
Number of sells
-
-9
-
Price
-
$1.04
Significant Holders of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) as of Q1 2025
50 filings reported holding UNBX - UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share as of Q1 2025.
UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.83M shares
of 17.2M outstanding shares and own 16.47% of the company stock.
Largest 10 shareholders include ARCH Venture Management, LLC (1M shares), VANGUARD GROUP INC (673K shares), Alyeska Investment Group, L.P. (292K shares), GEODE CAPITAL MANAGEMENT, LLC (166K shares), RENAISSANCE TECHNOLOGIES LLC (94.2K shares), BlackRock, Inc. (81.4K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (62.7K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (50K shares), Founders Fund V Management, LLC (49.2K shares), and MORGAN STANLEY (43.4K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.